US Patent Issued to OBIGEN PHARMA on Oct. 14 for "Botulinum toxin type a complex, and formulation thereof and usage method therefor" (Taiwanese Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,543, issued on Oct. 14, was assigned to OBIGEN PHARMA INC. (Zhubei, China).

"Botulinum toxin type a complex, and formulation thereof and usage method therefor" was invented by Tzu-Wen Tsau (Taipei, Taiwan), Yung-Kai Wang (Taipei, Taiwan), Kuan-Cheng Shen (Taipei, Taiwan), Yueh-Chin Wu (Taipei, Taiwan), Cheng-Der Tony Yu (Taipei, Taiwan) and Yu-Chun Tseng (Taipei, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a botulinum toxin type A complex, and a formulation thereof and a usage method therefor. The present invention provides the botulinum toxin type A complex, comprising an HA70 component, and an HA17 compon...